欧原醇与剂量相关的影响:在健康的Wistar大鼠中探索功能和形态
Renner Philipe Rodrigues Carvalho1, Rosiany Vieira da Costa1, Isadora Ribeiro de Carvalho1
1Laboratory of Structural Biology, Department of General Biology, Universidade Federal de Viçosa, Viçosa, Minas Gerais Brazil.
概括
尤根醇以剂量依赖的方式影响大鼠功能和形态. 较高剂量改变脏的生物化学,蛋白质组形状和结构,强调治疗用途的谨慎剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生化学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 尤根醇具有已知的药理性质.
- 有限的研究存在于eugenol对功能的特定影响.
- 了解这些影响对于安全的治疗应用至关重要.
研究的目的:
- 为了研究欧原醇对大鼠脏组织学,生物化学,氧化状况和蛋白质基因特征的剂量依赖性影响.
- 为了评估潜在的毒性和适应性反应对eugenol的管理.
- 为了建立安全的剂量准则eugenol的使用.
主要方法:
- 成年Wistar大鼠在60天的时间内通过输卵管服用了10,20和40毫克/公斤剂量的eugenol.
- 通过组织学检查,生化分析,氧化应激标志物和蛋白质组分析来评估功能.
- 具体参数包括总抗氧化能力,氧化水平,Na+/K+ ATPase活性和血清电解质度.
主要成果:
- 低剂量 (10毫克/公斤) 尤根醇显示氧化和血管增加,但没有功能或形态损伤.
- 中间剂量 (20 mg/kg) 抑制了Na+/K+ ATPase活性,并上调了线粒体和细胞防御蛋白.
- 高剂量 (40 mg/kg) 增加了血清电解质,抑制了Na+/K+ ATPase,诱导了氧化应激反应,并使近接管边界变薄.
结论:
- 尤根醇对大鼠功能和形态产生剂量依赖的作用.
- 蛋白质组分析显示,欧原醇影响能量代谢,氧化应激和线粒体通路.
- 这些发现强调了在治疗环境中需要精确的eugenol剂量,以减轻潜在的脏副作用.
更多相关视频
06:38Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
12.0K
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
23.5K
相关概念视频
01:22Dose-Response Relationship: Potency and Efficacy
4.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.2K
01:11Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62
01:03Dose-Response Relationship: Overview
2.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.9K